# TSPO Endothelial - EMPATHY

> **NCT07697183** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Imperial College London** · enrollment: 6 (estimated)

## Conditions studied

- PAH

## Interventions

- **DRUG:** XBD173

## Key facts

- **NCT ID:** NCT07697183
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-05-13
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2026-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07697183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07697183, "TSPO Endothelial - EMPATHY". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07697183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*